News

May 1, 2017May 1, 2017

BPH Patients More Likely to Take Their Meds than Those with Overactive Bladder, Study Finds

News

Real-world data involving some 332,000 people with either overactive bladder or benign prostatic hyperplasia (BPH) found that BPH patients were more persistent with their medication — continuing to use a treatment for its prescribed period ... Read more

April 28, 2017April 28, 2017

Rapaflo Treats LUTS Better Than Cialis in Short Run but Causes More Side Effects, Study Finds

News

Rapaflo (silodosin) was more effective than Cialis (tadalafil) in improving lower urinary tract symptoms (LUTS) caused by prostate enlargement in a study comparing the two drugs, though Rapaflo caused more ... Read more

April 26, 2017April 26, 2017

All Men With BPH Should Be Tested for Impotence, Bosnian Study Suggests

News

Severe lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) make men more likely to suffer from erectile dysfunction (ED), according to a Bosnian study that urges all men ... Read more

April 24, 2017

Cialis Is Less Effective but Safe BPH Treatment for Men 75 and Older, Analysis Says

News

Cialis (tadalafil) treatment in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) is less efficient but well-tolerated, a pool of Phase 2 and 3 clinical ... Read more

April 21, 2017April 21, 2017

Urologist at Texas Clinic Recognized for Expertise in Treating LUTS with UroLift System

News

Dr. Michael Trotter with Midtown Urology Associates, in Austin, Texas, was recently recognized for his expertise in treating urinary tract symptoms in patients using the UroLift System, and has been designated a ... Read more

April 19, 2017April 19, 2017

NeoTract Gets Innovation Award for Implants That Ease Enlarged Prostate Symptoms

News

NeoTract has received a Northern California business development group’s innovation award for creating implants that relieve the symptoms of enlarged prostate without surgery. The #Gamechanger Award was for the UroLift System, which ... Read more

April 17, 2017April 17, 2017

Veru Healthcare’s Tamsulosin Delayed Release Sachet for BPH Similar to Flomax, Company Says

News

Miami-based Veru Healthcare has determined that its Tamsulosin Delayed Release Sachet (DRS) for men with benign prostatic hyperplasia (BPH) has a similar biological profile to Flomax. The announcement comes after Veru — which ... Read more

April 12, 2017April 12, 2017

Researcher’s Suggestion of Menopause Link to Prostate Cancer Likely to Spark Debate

News

An Australian researcher has offered a new, and certain-to-be-controversial, hypothesis about why men develop an enlarged prostate and prostate cancer. It evolves from love making with women who are in ... Read more

April 10, 2017

Positive Results from Sophiris’ Phase 3 Trial of BPH Treatment Topsalysin Presented at Conference

News

Sophiris recently presented positive results from a Phase 3 clinical trial of its lead drug candidate topsalysin (PRX302) at the 16th Annual Needham Healthcare Conference April 4-5 in New York. The investigational ... Read more

April 7, 2017April 7, 2017

Diabetes Can Predict Prostate Cancer in BPH Patients Undergoing HoLEP, Study Suggests

News

Diabetes may predict high-risk prostate cancer in men with benign prostatic hyperplasia (BPH) undergoing treatment with Holmium laser enucleation of the prostate, according to a new Japanese study. Known as ... Read more